Ignite Creation Date:
2025-12-24 @ 10:09 PM
Ignite Modification Date:
2026-02-20 @ 6:01 PM
Study NCT ID:
NCT04626635
Status:
RECRUITING
Last Update Posted:
2025-12-03
First Post:
2020-11-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-21
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08-19
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-12
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-06
First Submit QC Date:
None
Study First Post Date:
2020-11-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-02
Last Update Post Date:
2025-12-03
Last Update Post Date Type:
ESTIMATED